Detection of prostate cancer by an electronic nose: A proof of principle study

Journal of Urology

Volumn 192, Issue 1, 2014, Pages 230-235

  Roine, Antti ^a   Veskimäe, Erik ^a   Tuokko, Antti ^a   Kumpulainen, Pekka ^a   Koskimäki, Juha ^a   Keinänen, Tuomo A ^c   Häkkinen, Merja R ^d   Vepsäläinen, Jouko ^d   Paavonen, Timo ^b   Lekkala, Jukka ^a   Lehtimäki, Terho ^a   Tammela, Teuvo L ^a   Oksala, Niku K J ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

electronic nose; prostatic hyperplasia; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC NOSE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SIZE; PROSTATE VOLUME; PROSTATECTOMY; ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY; ROBOTICS; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION; URINALYSIS; DIAGNOSTIC ERROR; PROSPECTIVE STUDY; ROBOTIC SURGICAL PROCEDURE; TUMOR VOLUME; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; URINE;

AGED; DIAGNOSIS, DIFFERENTIAL; ELECTRONIC NOSE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84902548813     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.01.113     Document Type: Article

References (30)

1. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69
2. A. Heidenreich, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61
3. B. Holmström, M. Johansson, and A. Bergh et al. Prostate specific antigen for early detection of prostate cancer: longitudinal study BMJ 339 2009 b3537
4. J. Feliciano, E. Teper, and M. Ferrandino et al. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 179 2008 952
5. M.J. Roobol, and S.V. Carlsson Risk stratification in prostate cancer screening Nat Rev Urol 10 2012 38
6. H. Williams, and A. Pembroke Sniffer dogs in the melanoma clinic? Lancet 1 1989 734
7. C.M. Willis, S.M. Church, and C.M. Guest et al. Olfactory detection of human bladder cancer by dogs: proof of principle study BMJ 329 2004 712
8. M. McCulloch, T. Jezierski, and M. Broffman et al. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers Integr Cancer Ther 5 2006 30
9. H. Sonoda, S. Kohnoe, and T. Yamazato et al. Colorectal cancer screening with odour material by canine scent detection Gut 60 2011 814
10. R.T. Gordon, C.B. Schatz, and L.J. Myers et al. The use of canines in the detection of human cancers J Altern Complement Med 14 2008 61
11. J.N. Cornu, G. Cancel-Tassin, and V. Ondet et al. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis Eur Urol 59 2011 197
12. Lippi G: Re: Jean-Nicolas Cornu, Géraldine Cancel-Tassin, Valérie Ondet et al. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. Eur Urol 2011; 59: 197-201. Eur Urol 2011; 60: e29.
13. A.S. Bjartell Dogs sniffing urine: a future diagnostic tool or a way to identify new prostate cancer markers? Eur Urol 59 2011 202
14. G. Lippi, and G. Cervellin Canine olfactory detection of cancer versus laboratory testing: myth or opportunity? Clin Chem Lab Med 50 2011 435
15. A.D. Wilson, and M. Baietto Advances in electronic-nose technologies developed for biomedical applications Sensors (Basel) 11 2011 1105
16. A.D. Wilson, and M. Baietto Applications and advances in electronic-nose technologies Sensors 9 2009 5099
17. A. D'Amico, G. Pennazza, and M. Santonico et al. An investigation on electronic nose diagnosis of lung cancer Lung Cancer 68 2010 170
18. G. Peng, M. Hakim, and Y.Y. Broza et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors Br J Cancer 103 2010 542
19. B.J. Trock Application of metabolomics to prostate cancer Urol Oncol 29 2011 572
20. M. Bernabei, G. Pennazza, and M. Santonico et al. A preliminary study on the possibility to diagnose urinary tract cancers by an electronic nose Sens Actuators B Chem 131 2008 1
21. A. Roine, M. Tolvanen, and M. Sipiläinen et al. Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose Future Oncol 8 2012 1157
22. M. Utriainen, E. Kärpänoja, and H. Paakkanen Combining miniaturized ion mobility spectrometer and metal oxide gas sensor for the fast detection of toxic chemical vapors Sens Actuators B Chem 93 2003 17
23. C.M. Bishop Pattern Recognition and Machine Learning 2006 Springer New York 1 66
24. T. DiCiccio, and B. Efron Bootstrap confidence intervals Stat Sci 11 1996 189
25. N.R. Draper, and H. Smith Applied Regression Analysis 3rd ed 1998 John Wiley & Sons, Inc. New York
26. T. Zhang, D.G. Watson, and L. Wang et al. Application of holistic liquid chromatography-high resolution mass spectrometry based urinary metabolomics for prostate cancer detection and biomarker discovery PLoS One 8 2013 e65880
27. J.E. Oesterling, S.J. Jacobsen, and C.G. Chute et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges JAMA 270 1993 860
28. I.M. Thompson, D.P. Ankerst, and C. Chi et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 2005 66
29. M.E. Chen, D.A. Johnston, and K. Tang et al. Detailed mapping of prostate carcinoma foci: biopsy strategy implications Cancer 89 2000 1800
30. K.A. Roehl, J.A. Antenor, and W.J. Catalona Serial biopsy results in prostate cancer screening study J Urol 167 2002 2435